Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
<p>A vaccine against tuberculosis (TB), a disease resulting after infection with <em>Mycobacterium tuberculosis</em> (M.tb), is urgently needed to prevent more than a million deaths per year. Bacillus Calmette–Guérin (BCG) is the only available vaccine against TB but its efficacy i...
| Päätekijä: | |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Opinnäyte |
| Kieli: | English |
| Julkaistu: |
2018
|
| Aiheet: |